Paraganglioma classification: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(9 intermediate revisions by 4 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Paraganglioma}}
{{Paraganglioma}}
{{CMG}} {{AE}} {{AAM}}  
 
{{CMG}}; {{AE}} {{Asem}}
==Overview==
==Overview==
Paraganglioma may be classified into several subtypes based on site of origin and having a neural cell line.
Pheochromocytomas and paragnagliomas (collectively referred to as PPGLs) are rare tumors that originate from chromaffin cells in the adrenal medulla (pheochromocytoma) and extra-adrenal neural ganglia (paraganglioma). These tumors can be biochemically active (producing catecholamines) or silent. PPGLs can also be classified as either sporadic or familial, with association extablished to several familial syndromes.
 
PPGLs can be either benign or malignant. However, the definition of malignancy is established by the presence of metastasis as benign and malignant tumors in this category are indistinguishable in their histological and biochemical characteristics. Extent of spread of tumor is another factor that classifies PPGLs, putting them into the categories of local, regional and metastatic.


==Classification==
==Classification==
According to the [[World Health Organization]], paragangliomas are classified as having a neural cell line. In the categorization proposed by Wick, the paragangliomas belong to Group II.


Paragangliomas are also described by their site of origin and are often given special names:
There are several way to classify pheochromocytomas and paragangliomas (PPGLs), including:
 
===Origin of Tumor===
PPGLs may be classified according to their site of origin into:
*Pheochromocytoma: tumor originates from chromaffin cells in the adrenal medulla. (80-85%)
*Paraganglioma: tumor originates from chromaffin cells in extra-adrenal neural ganglia. (15-20%) These can have a sympathetic origin (sympathetic chain in thorax, abdomen and pelvis) or a parasympathetic origin (in neck, head and skull base).
 
 
===Extent of Spread===
Both pheochromocytomas and paragangliomas may be classified into 3 subcategories based on spread:
*Local.
*Regional.
*Metastatic.
These 3 categories share the same histological and biochemical characteristics. Metastasis is considered the definition of malignancy in PPGLs. Non-metastatic PPGLs are considered benign.
 
 
===Biochemical Profile===
Most PPGLs are biochemically active, producing varying amounts of catecholamines like epinephrine, norepinephrine and dopamine, but rarely, they can be biochemically silent.
 
For pheochromocytomas (adrenal tumors) , the split is halfway between tumors with adrenergic phenotype and those with a noradrenergic phenotype (half adrenergic, half noradrenergic). Paragangliomas (extra-adrenal tumors) that arise from sympathetic ganglia produce noradrenaline (predominantly or even exclusively), while those in the head and base of skull don't usually produce catecholamines save for some dopamine and its metabolite 3-methoxytyramine.
 


* '''Carotid paragangliomas'''
* '''Glomus tympanicum''' and '''Glomus jugulare''' paragangliomas
* '''Vagal paragangliomas'''
* '''Other sites''' such as [[larynx]], nasal cavity, paranasal sinuses, [[thyroid]] gland, [[thoracic inlet]], as well as the bladder in extremely rare cases.
==References==
==References==
{{reflist|2}}
{{Reflist|2}}
{{Epithelial neoplasms}}
{{WH}}
{{WikiDoc Help Menu}}
{{WS}}
{{WikiDoc Sources}}
[[Category: (name of the system)]]
[[Category:Disease]]
[[Category:Types of cancer]]
[[Category:Mature chapter]]

Latest revision as of 19:01, 13 February 2019

Paraganglioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Paraganglioma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT Scan

MRI

Echocardiography and Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Paraganglioma classification On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Paraganglioma classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Paraganglioma classification

CDC on Paraganglioma classification

Paraganglioma classification in the news

Blogs on Paraganglioma classification

Directions to Hospitals Treating Paraganglioma

Risk calculators and risk factors for Paraganglioma classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Asem Juhani, M.D.[2]

Overview

Pheochromocytomas and paragnagliomas (collectively referred to as PPGLs) are rare tumors that originate from chromaffin cells in the adrenal medulla (pheochromocytoma) and extra-adrenal neural ganglia (paraganglioma). These tumors can be biochemically active (producing catecholamines) or silent. PPGLs can also be classified as either sporadic or familial, with association extablished to several familial syndromes.

PPGLs can be either benign or malignant. However, the definition of malignancy is established by the presence of metastasis as benign and malignant tumors in this category are indistinguishable in their histological and biochemical characteristics. Extent of spread of tumor is another factor that classifies PPGLs, putting them into the categories of local, regional and metastatic.

Classification

There are several way to classify pheochromocytomas and paragangliomas (PPGLs), including:

Origin of Tumor

PPGLs may be classified according to their site of origin into:

  • Pheochromocytoma: tumor originates from chromaffin cells in the adrenal medulla. (80-85%)
  • Paraganglioma: tumor originates from chromaffin cells in extra-adrenal neural ganglia. (15-20%) These can have a sympathetic origin (sympathetic chain in thorax, abdomen and pelvis) or a parasympathetic origin (in neck, head and skull base).


Extent of Spread

Both pheochromocytomas and paragangliomas may be classified into 3 subcategories based on spread:

  • Local.
  • Regional.
  • Metastatic.

These 3 categories share the same histological and biochemical characteristics. Metastasis is considered the definition of malignancy in PPGLs. Non-metastatic PPGLs are considered benign.


Biochemical Profile

Most PPGLs are biochemically active, producing varying amounts of catecholamines like epinephrine, norepinephrine and dopamine, but rarely, they can be biochemically silent.

For pheochromocytomas (adrenal tumors) , the split is halfway between tumors with adrenergic phenotype and those with a noradrenergic phenotype (half adrenergic, half noradrenergic). Paragangliomas (extra-adrenal tumors) that arise from sympathetic ganglia produce noradrenaline (predominantly or even exclusively), while those in the head and base of skull don't usually produce catecholamines save for some dopamine and its metabolite 3-methoxytyramine.


References

Template:WH Template:WS